Skip to main content
Log in

Long-term oral ciprofloxacin for infection prophylaxis in allogeneic bone marrow transplantation

  • Published:
Pharmaceutisch Weekblad Aims and scope Submit manuscript

Abstract

The efficacy of oral ciprofloxacin to prevent bacterial infections during the first three months after allogeneic bone marrow transplantation (BMT) was assessed prospectively. Twenty-three recipients of lymphocyte depleted marrow grafts received ciprofloxacin orally, 500 mg twice daily for 90 days after BMT. Nine patients had no infections during ciprofloxacin prophylaxis; in the remaining 14 patients 19 febrile episodes occurred. No infections could be attributed to Gram-negative rods nor to fungal micro-organisms on the basis of the micro-organisms isolated. One infection, a pneumonia due toBacteroides melaninogenicus, proved to be fatal. Allergic skin reactions were observed in three patients, but neither hematological nor nephrological side-effects could be substantiated in patients who were treated concomitantly with cyclosporine. Prolonged administration of ciprofloxacin turned out to be safe and effective in preventing serious aerobic bacterial infections during the first three months after BMT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Winston DJ, Ho G, Champlin RE, and Gale RP. Infectious complications of bone marrow transplantation. Exp Hematol 1984;12:205–15.

    PubMed  Google Scholar 

  2. Van der Waay D. Colonization resistance of the digestive tract: clinical consequences and implications. J Antimicrob Chemother 1982;10:263–70.

    PubMed  Google Scholar 

  3. Thompson JF, Chalmers DHK, Hunnisett AGW, Wood RFM, Morris PJ. Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporin. Transplantation 1983;36:204–7.

    PubMed  Google Scholar 

  4. Brumfitt W, Franklin I, Grady D, Hamilton-Miller JMT, and Iliffe A. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother 1984;26:757–61.

    PubMed  Google Scholar 

  5. Muytjens HL, Van der Ros-van de Repe J, Van Veldhuizen G. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and naladixic acid. Antimicrob Agents Chemother 1983;24:302–4.

    PubMed  Google Scholar 

  6. De Witte T, Raymakers R, Plas A, Koekman E, Wessels J, and Haanen C. Bone marrow repopulation capacity after allegeneic bone marrow transplantation of lymphocyte depleted bone marrow using counterflow centrifugation. Transplantation 1984;37:151–5.

    PubMed  Google Scholar 

  7. Cohen J, Donelly JP, Worsley AM, et al. Septicemia caused by viridans streptococci in neutropenic patients with leukemia. Lancet 1983;II:1452–4.

    Google Scholar 

  8. Winston DJ, Ho WG, Nakao SL, Gale RP, and Champlin RE. Norfloxacin versus Vancomycin/Polymyxin for prevention of infections in granulocytopenic patients. Am J Med 1986;80:884–90.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Witte, T., Novakova, I., Branolte, J. et al. Long-term oral ciprofloxacin for infection prophylaxis in allogeneic bone marrow transplantation. Pharmaceutisch Weekblad Scientific Edition 9 (Suppl 1), S48–S52 (1987). https://doi.org/10.1007/BF02075260

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02075260

Key words

Navigation